The current GRAL market cap is 901.51M. The company's latest EPS is USD -43.6206 and P/E is -0.62.
Quarter End | Sep 2024 |
---|---|
USD ($) | |
Total Revenue | 28.65M |
Operating Income | -183.51M |
Net Income | -125.69M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Revenue | 93.11M |
Operating Income | -1.52B |
Net Income | -1.47B |
Quarter End | Sep 2024 |
---|---|
USD ($) | |
Total Assets | 3.12B |
Total Liabilities | 530.32M |
Total Equity | 2.59B |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Assets | 3.91B |
Total Liabilities | 267.63M |
Total Equity | 3.65B |
Market Cap | 901.51M |
Price to Earnings Ratio | -0.62 |
Price to Sales Ratio | 9.7 |
Price to Cash Ratio | 9.29 |
Price to Book Ratio | 0.25 |
Dividend Yield | - |
Shares Outstanding | 33.6M |
Average Volume (1 week) | 1.98M |
Average Volume (1 Month) | 939.02k |
52 Week Change | 44.02% |
52 Week High | 29.79 |
52 Week Low | 12.33 |
Spread (Intraday) | 0.19 (0.7%) |
Company Name | GRAIL Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://grail.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.